VESICULAR PALMOPLANTAR ECZEMA

 

Key points


·       An acute and/or chronic dermatitis clinically characterized by small to large blisters on the palms and soles and histopathology by spongiotic vesicles.

·       Considered an endogenous dermatitis, but can be exacerbated by exogenous factors, most notably irritant and allergic contact dermatitis. In addition, atopy may in some cases predispose to the development of vesicular palmoplantar eczema.

·       Can be divided into four categories: (1) pompholyx, (2) chronic vesiculobullous hand dermatitis, (3) hyperkeratotic hand dermatitis, and (4) id reactions.

·       Does not respond well to treatment.

 


 

Pompholyx


Salient features

 

·       Firm, pruritic vesicles of the palms, soles, and lateral and medial aspects of the fingers and toes

 

·       Association with atopic dermatitis and contact dermatitis (allergic and irritant)

 

·       No disturbance of sweat gland function

 

Introduction

 

Pompholyx is an idiopathic, common, chronic, relapsing palmoplantar eczematous dermatosis characterized by firm, pruritic vesicles and bullae.  Pompholyx is not an independent disease entity because it is often a manifestation of other types of eczema, especially atopic dermatitis and irritant or allergic contact dermatitis. Pompholyx is a special vesicular type of hand and foot dermatitis. Acute, chronic or recurrent dermatosis of the fingers, palms, and soles.

Pompholyx is a form of eczema of the palms and soles in which edema fluid accumulates (spongiosis) within the epidermis to form visible vesicles or bullae. As a result of the thick tear-proof horny layer in these sites, the blisters tend to become relatively large before they burst. Pompholyx probably accounts for about 5–20% of all cases of hand eczema. When pompholyx occurs on the palms, it may be called ‘cheiropompholyx’, and when on the soles, ‘podopompholyx’. The term ‘dyshidrotic eczema’ as an alternative to pompholyx hand eczema has been dropped because no causal relationship with the sweat glands or sweating has been demonstrated.

 

Pathogenesis

 

Although the formation of vesicles is not linked to sweat gland dysfunction or trapping of sweat within the epidermis, hyperhidrosis can be an aggravating factor in some patients. Notably, treatment of hyperhidrosis with onabotulinum toxin A may ameliorate pompholyx. Pompholyx is frequently an expression of atopic dermatitis, particularly as a late-stage manifestation. In these patients, its intensity is usually low to moderate with a protracted and relapsing course, and it is accompanied by only a few other signs of atopic dermatitis. Less often, pompholyx is a manifestation of acute or subacute allergic contact dermatitis. Flares can also result from exposure to known irritants.

Occasionally, administration of IVIg is followed by acute episodes of pompholyx. The role of ingestants, in particular nickel and cobalt, has been debated, but improvement with a low-nickel diet (in nickel-sensitive patients with a positive oral provocation test) has been observed. Lastly, flares can also follow periods of emotional stress as well as exposure to hot climates and rarely sunlight.

 

Clinical Features


Pompholyx


It is characterized by explosive outbreak (sudden onset) of symmetric, firm, deep-seated vesicles of the palms, the lateral and medial aspects of the fingers, and less often the soles and toes. Discomfort and itching usually precede the development of the vesicles. The size of the vesicles may vary from pinhead-sized to several centimeters. Intact large bullae can be drained, but should not be unroofed. However, large bullae may rupture spontaneously, leaving oozing or dried up erosions. When smaller lesions are clustered, they have been likened to tapioca pudding. While the vesicles initially contain clear fluid, they have a tendency for purulent super infection. This acute phase resolves via desquamation of characteristically thick scales. Later fissures and lichenification may occur.  Individual outbreaks are usually self-limited over 2-3 weeks. Recurrent attacks are the rule. Attacks are most common among adolescents and young adults and seem to be more common in the spring and summer months.

Histologically, spongiotic dermatitis is seen with the formation of micro- and macrovesicles within the epidermis. There is no association with sweat glands.

 

 

Keratolysis exfoliativa (recurrent focal palmar peeling)


It is a chronic, asymptomatic, and noninflammatory peeling of the on the sides of the fingers and on the palms or on the feet, which displays no blisters and most commonly seen during the summer months. It is thought to occur more frequently in people with hyperhidrosis in these areas. Scaling usually starts from one to two fine points and expands outward to form small to larger annular collarettes of white scale. The condition is usually self-limited and requiring only emollients. The condition is sometimes a mild form of pompholyx. Some patients subsequently develop true pompholyx.

 

 

Chronic Vesiculobullous Dermatitis

 

++Chronic vesiculobullous hand dermatitis is more common than pompholyx and more difficult to manage because of its relapsing course. The clinical presentation includes small 1- to 2-mm vesicles filled with clear fluid localizing to the lateral aspects of the fingers, palms, and soles as in pompholyx. As the condition becomes more chronic, the clinical appearance may evolve and subsequently appear more fissured and hyperkeratotic. A clear history of vesicles or exacerbations characterized by blistering may help to narrow the classification of a given presentation of hand dermatitis.

 

 

Hyperkeratotic Hand Dermatitis

 

++Patients with hyperkeratotic hand dermatitis are usually middle-aged to elderly male and generally present with chronic hyperkeratotic scaly, pruritic plaques, sometimes with fissures on the central palm and are often very refractory to treatment. Plantar involvement is present in a minority of cases.

++

 

ID Reaction (Auto sensitization dermatitis)

 

++++Auto sensitization dermatitis refers to a phenomenon in which an acute dermatitis develops at cutaneous sites distant from an inflammatory focus, and where the secondary acute dermatitis is not explained by the inciting cause of the primary inflammation. The phenomenon results from the release of cytokines in the primary dermatitis, as a result of sensitization. These cytokines circulate in the blood and heighten the sensitivity of the distant skin areas. The diagnosis of auto sensitization dermatitis is often post hoc; i.e. the distant eruption disappears when the primary dermatitis is controlled.

Disseminated eczema appears later than the primary lesions. Typically, 1 to 2 weeks after an acute inflammation, there is sudden development of an extremely pruritic, and symmetric, scattered, erythematous eruption with macules, papules, and vesicles develop. Predilection for analogous body sites (e.g. extensor aspects of the lower and upper extremities, palms and soles).

The eruption involves the forearms, thighs, legs, trunk, face, hands (lateral aspects of the fingers and the palms), neck, and feet in descending order of frequency. During the evolution of the dermatitis, its morphology may change in a manner consistent with the chronicity (i.e., vesicles to scale).

For example, a patient with venous stasis dermatitis on the lower legs may develop pruritic, symmetric, scattered, erythematous, maculopapular, or papulovesicular lesions on the trunk, forearms, thighs, or legs. Similarly, auto sensitization may occur as an "id reaction in inflammatory tinea pedis and manifests as a dyshidrosiform, vesicular eruption on the feet and hands and papulovesicular eczematoid lesions on the trunk.

These persist and spread until the basic underlying primary dermatitis is controlled.

Treatment of the underlying disease results in resolution.

 

++Diagnosis

 

++The diagnosis of vesiculobullous hand dermatitis is usually made on the basis of clinical presentation, history, and sometimes histology.

 

 

Differential diagnosis

 

In most cases of psoriasis on the hands, however, the silvery nature of the scale, involvement of the knuckles, sharply demarcated ‘scalloped’ edges to the erythema along the borders of the hands and fingers, and the relative absence of pruritus are helpful pointers. A family history of psoriasis and the presence of nail pits in the absence of nail fold lesions are also suggestive.

Tinea manuum can be missed, particularly when it is extensive or secondarily infected. Unilateral scaling of the palm should always suggest a possible Trichophyton infection.

Pompholyx can resemble palmoplantar pustulosis. Clinically, the two conditions are distinguished by the presence of vesicles in the former and sterile pustules that resolve with characteristic brown marks in the latter. Repeated attacks of pompholyx may produce hyperkeratotic lesions that mimic psoriasis vulgaris.

Atopic hand dermatitis is associated with a number of factors: hand dermatitis before age 15 years, persistent eczema on the body, dry or itchy skin in adult life, and widespread atopic dermatitis in childhood. The backs of the hands, particularly the fingers, are affected with erythema, vesiculation, crusting, excoriation, and scale.

It must be emphasized that the whole skin should be examined in any case of hand eczema in which the diagnosis is in doubt. There may, for example, be evidence of nickel allergy or tinea pedis, or small patches of psoriasis of which the patient is unaware.

 

 

Disease course and prognosis

 

Unless a responsible allergen can be identified and removed, the prognosis of hand eczema for an individual is uncertain. Even if a relevant allergen is identified, it may be difficult to avoid the offending allergens such as nickel and fragrance. Atopic hand eczema probably has the worst prognosis of all types of hand eczema. In general, eczema on the dorsa of the hands clears more readily, and is less likely to recur than palmar eczema.

Pompholyx has an unpredictable course. Following an acute attack of pompholyx, about onethird of patients experience no further episodes, onethird suffer from recurrent episodes and in the remainder the condition develops into a chronic, possibly hyperkeratotic phase. Those forms of hand eczema that are due to the effects of irritants carry a particularly poor prognosis unless these irritants can be completely removed. The condition seems to flare when a susceptible person is under stress that is greater than can be handled with serenity.

Patients who have suffered from severe hand eczema will often remain vulnerable to mild irritants for several months after the eczema has apparently cleared. Interdigital dermatitis has been shown to be a potential precursor to more severe hand dermatitis in hairdressers. Recognition of this sign by the patient may allow early intervention to prevent progression of the disease.

 

Investigations

 

A circumscribed and asymmetrical area of scaling and vesiculation of the palm or sole should suggest the possibility of dermatophytosis, and scrapings should be examined for fungus. If the erythema is limited to one or two interdigital clefts, or is asymmetrical, or involves the dorsal skin to any extent, the possibility of a contact dermatitis must be considered and investigated by patch testing. If there are immediate symptoms on wearing latex gloves, then type 1 latex hypersensitivity should be excluded with latex prick testing.

 

 

Management

 

 

Chronic hand eczema

 

Topical treatment

 

Management of chronic hand eczema, defined as persisting for at least 6 weeks, and involves the avoidance of irritants, frequent application of emollients and use of topical corticosteroids when indicated.

Avoidance of irritants is particularly difficult for patients with hand eczema because they are so ubiquitous. Patient education is of paramount importance and this can be reinforced by printed advice sheets. Gloves usually provide the best protection against irritants. Rubber gloves generally give good protection for housework. In patients with a rubber allergy, polyvinyl chloride household gloves should be worn instead, but some allergens, such as acrylates and epoxy resins, can penetrate vinyl or rubber gloves. Gloves that develop holes should be discarded immediately and, if sweating makes the condition worse, it may be helpful to wear cotton gloves beneath the protective ones.

Barrier creams are used in an attempt to prevent hand eczema of occupational origin.

Emollients should be applied frequently, and containers should be left at convenient locations at home and at work so that they are readily available. In general, choice of emollient is directed by the patient to ensure maximal compliance. Soap substitutes should be used in place of soap for all hand washing. Patients should be warned that some topical preparations that can contain irritants such as alcohol or propylene glycol should be avoided.

Topical corticosteroids are required for all but the mildest cases of hand eczema. For severe hand eczema, potent or very potent topical corticosteroids may be needed. Painful fissures of the fingertips are a particular therapeutic problem and these can be treated with corticosteroidimpregnated adhesive tape, which provides both physical protection and local delivery of topical corticosteroid.

In difficult, unresponsive cases the use of a topical corticosteroid under occlusion may be considered. The steroid is applied at bedtime, and polythene gloves, sealed at the wrist with sticky tape, are worn overnight. This can be an effective treatment, but it greatly increases the risk of atrophy and secondary bacterial infection, and should be discontinued as soon as the eczema shows satisfactory improvement. After improvement with daily corticosteroid use, the intermittent use of a potent corticosteroid cream can be used safely to prevent relapse.

If hand eczema does not respond to topical corticosteroid therapy, the possibility of tinea, exposure to irritants or allergens, or contact sensitization to medicament bases, preservatives or the corticosteroid itself should be considered, with patch testing if necessary.

Topical calcineurin inhibitors provide a further option for treating hand eczema. Topical tacrolimus is shown to be as effective as momethasone furoate 0.1% ointment in patients with vesicular pompholyx of the palms. After 2 weeks of treatment, there is significant improvement. The response to tacrolimus is better on the palms than soles.

Hyperkeratotic palmar eczema is notoriously difficult to manage. Topical retinoids and calcipotriene, both of which act to regulate epidermal cell maturation, have been shown to improve this category of hand dermatitis. ++Tar pastes have been used for chronic unresponsive cases and salicylic acid ointment is also sometimes helpful for hyperkeratosis and persistent scaling. Intradermal injection of triamcinolone (10 mg/mL) into recalcitrant, localized patches of hand eczema may also be beneficial.

 

 

Phototherapy

 

Oral psoralen and UVA (PUVA) phototherapy and UVB therapy have been used to treat chronic hand eczema and evidence suggests that oral PUVA may be more effective than UVB. Topical hand PUVA soaks are frequently used in clinical practice for hand eczema but they are less effective for hyperkeratotic hand eczema.

 

 

Systemic Therapy

 

At present, the retinoid alitretinoin (9cisretinoic acid) is the only licensed systemic therapy for chronic hand eczema who has failed potent topical corticosteroid therapy. It interacts with both retinoid X and retinoic acid receptors. After 24 weeks of alitretinoin 30 mg daily, 48% of patients were clear or almost clear of their hand eczema. Mucocutaneous adverse effects are less common than for other systemic retinoids and the commonest issue reported was headache, which occurred in onefifth of patients.

++

For recurrent pompholyx and chronic vesicular dermatitis, oral prednisone may be required and is often effective if treatment is initiated early, at the onset of the itching prodrome. However, because of significant side effects, systemic glucocorticoids are typically inappropriate for long-term management.

++

Cyclosporine is used at dose of 3 mg/kg/day with a potent topical corticosteroid in the treatment of chronic vesicular dermatitis. Although patients showed improvement with treatment, relapses occurred shortly after discontinuation of cyclosporine.

++

Mycophenolate mofetil has been used in the treatment of chronic vesicular dermatitis at dosing levels of 2–3 g/day (in divided doses). It has been anecdotally shown to improve chronic vesicular dermatitis that has been otherwise recalcitrant to corticosteroids, and phototherapy. However, it has also been anecdotally shown to induce biopsy-proven dyshidrotic eczema.++

 

Azathioprine 50 mg daily with a very potent topical corticosteroid gives possible additive benefit from lowdose azathioprine.

 

Methotrexate In chronic vesicular eczema, it has been reported to partially or completely clears lesions at low doses ranging from 12.5 to 22.5 mg/week. However, its wide spectrum of potential side effects remains a limiting factor to its use in this particular skin disease.

 

Acute hand eczema

 

For hand eczema that presents acutely, it is important to eliminate any precipitant, for example a contact allergen. Emollients should be applied copiously. For exudates lesions, dilute potassium permanganate soaks are helpful. Large bullae may be aspirated using a sterile syringe. In severe cases, a short course of prednisone is given starting with 70 mg and tapering by 10 or 5 mg over 7 or 14 days.  Systemic antibiotics will be required if secondary bacterial infection develops.

++

 

Therapeutic ladder


First line

·        Hand care advice

·        Irritant and allergen avoidance

·        Emollients

·        Soap substitute


Second line

·        Potent or very potent topical corticosteroids


Third line

·        Alitretinoin/PUVA/azathioprine/ciclosporin/methotrexate

 

Popular Posts